A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

$1 Million COVID-19 Relief Fund is Launched by Inspire Brands: Fund to Support Childhood Hunger, Restaurant Industry Workers

The Inspire Brands Foundation, the charitable arm of Inspire Brands, is proud to announce the launch of a one million dollar COVID-19 relief fund, dedicated to supporting childhood hunger and restaurant industry relief efforts.

The initial disbursement from the fund is a $100,000 grant from the Arby’s Foundation, a division of the Inspire Brands Foundation, to support GENYOUth, a non-profit organization dedicated to creating healthier school communities. These funds will support GENYOUth’s newly established COVID-19 Emergency School Nutrition Fund and will provide up to 33 schools across the country grants of $3,000 each to purchase supplies for meal distribution and delivery.

“As a restaurant company, serving others is at the heart of who we are and how we operate,” said Stuart Brown, executive director of the Inspire Brands Foundation. “We’re hopeful that with community support, we can grow this fund beyond our initial investment, allowing us to serve more impacted youth and restaurant workers through the summer months and beyond.”

To help support / donate America’s youth and restaurant industry workers through a charitable donation, please visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy